|
PTPN1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.08733030859776E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
6.53189724530989E-11 |
| Normal-vs-Stage2 |
1.83589999980249E-07 |
| Normal-vs-Stage3 |
2.68110000867239E-09 |
| Normal-vs-Stage4 |
1.73959999960616E-07 |
| Stage1-vs-Stage2 |
3.876400E-01 |
| Stage1-vs-Stage3 |
4.048200E-01 |
| Stage1-vs-Stage4 |
4.832600E-01 |
| Stage2-vs-Stage3 |
8.334400E-01 |
| Stage2-vs-Stage4 |
8.811000E-01 |
| Stage3-vs-Stage4 |
9.595600E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.18580034680349E-10 |
| Normal-vs-AfricanAmerican |
2.139100E-03 |
| Normal-vs-Asian |
6.71700000065556E-08 |
| Caucasian-vs-AfricanAmerican |
4.327600E-01 |
| Caucasian-vs-Asian |
3.979200E-01 |
| AfricanAmerican-vs-Asian |
1.638400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.03230000103594E-08 |
| Normal-vs-Female |
1.50719999814086E-08 |
| Male-vs-Female |
7.619000E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
7.19570000251579E-08 |
| Normal-vs-Age(41-60Yrs) |
2.66480004729175E-09 |
| Normal-vs-Age(61-80Yrs) |
1.48279999390155E-09 |
| Normal-vs-Age(81-100Yrs) |
1.251020E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.605900E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.725400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.377600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.724000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.203800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.937780E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
2.437600E-01 |
| Classical-VS-Follicular |
1.242690E-04 |
| Classical-VS-Other |
1.451400E-01 |
| Classical-VS-Normal |
6.14960000033804E-07 |
| Tall-VS-Follicular |
2.363600E-01 |
| Tall-VS-Other |
4.179800E-01 |
| Tall-VS-Normal |
1.80643999999619E-05 |
| Follicular-VS-Other |
8.710200E-01 |
| Follicular-VS-Normal |
4.94193574951396E-12 |
| Other-VS-Normal |
1.735500E-03 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
8.05350008903361E-10 |
| Normal-vs-N1 |
1.43630000115635E-08 |
| N0-vs-N1 |
7.240000E-01 |
|
|
